Physician profile
Darrell M Cheek
NPI 1932100724
$6,529.57
in general payments reported to CMS, 2019-2025
46 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $236 · 2021: $893 · 2022: $787 · 2023: $1,829 · 2024: $859 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,304 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,304.00 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,432.77 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Shield Therapeutics INC | $575.88 | 2023-2024 | Accrufer |
| Lilly USA, LLC | $542.52 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.46 | 2020-2025 | Synjardy, Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $295.52 | 2020-2025 | Farxiga, Breztri, Tezspire |
| Pfizer INC. | $293.86 | 2021-2025 | |
| Dexcom, INC. | $252.21 | 2021-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $240.96 | 2021-2025 | Repatha, Otezla, Otezla |
| Esperion Therapeutics, INC. | $239.71 | 2020-2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $208.21 | 2022-2024 | Quviviq |
| Genzyme Corporation | $162.87 | 2025 | |
| Abbvie INC. | $144.06 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.98 | 2021-2025 | Trintellix, Glassia |
| Sanofi-Aventis U.S. LLC | $123.77 | 2022-2025 | |
| Glaxosmithkline, LLC. | $119.31 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $107.38 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Ani Pharmaceuticals, INC. | $102.25 | 2025 | Purified Cortrophin Gel |
| Biohaven Pharmaceutical Holding Company LTD. | $89.49 | 2022 | |
| Verity Pharmaceuticals INC. | $89.16 | 2024-2025 | Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.00 | 2021-2024 | Xifaxan, Trulance |
| Xeris Pharmaceuticals, INC. | $86.29 | 2023-2025 | Gvoke Hypopen |
| Beta Bionics, INC. | $66.10 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $61.20 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.93 | 2021-2025 | |
| Invivyd INC | $58.83 | 2025 | Pemgarda |
| Currax Pharmaceuticals LLC | $54.42 | 2021-2023 | Nexletol |
| Alexion Pharmaceuticals, INC. | $53.10 | 2024-2025 | Strensiq |
| Novartis Pharmaceuticals Corporation | $49.83 | 2022-2024 | |
| Ucb, INC. | $46.34 | 2025 | Bimzelx |
| Dynavax Technologies Corporation | $44.34 | 2023-2024 | Heplisav-B |
| Janssen Biotech, INC. | $41.17 | 2025 | Tremfya |
| Astellas Pharma US INC | $38.33 | 2023-2024 | Veozah |
| Baxter Healthcare | $33.94 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Exact Sciences Corporation | $31.26 | 2023-2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $26.47 | 2024 | Korlym |
| Electromed, INC. | $25.49 | 2025 | Smartvest |
| Madrigal Pharmaceuticals | $24.91 | 2025 | Rezdiffra |
| Sequel Med Tech, LLC | $22.81 | 2025 | Twiist |
| Liquidia Technologies, INC. | $21.35 | 2025 | Yutrepia |
| Averitas Pharma INC. | $20.03 | 2024 | Qutenza |
| Organon LLC | $19.51 | 2025 | Hadlima |
| Horizon Therapeutics Plc | $18.55 | 2023 | Krystexxa |
| Actelion Pharmaceuticals US, INC. | $17.89 | 2025 | Opsumit |
| Janssen Pharmaceuticals, INC | $17.25 | 2023 | Xarelto |
| Biohaven Pharmaceuticals, INC. | $13.64 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Cheek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.